An alternative approach to the treatment of type I diabetes is the use of genetically altered neoplastic liver cells to synthesize, store and secrete insulin. To try and achieve this goal we modified a human liver cell line, HUH7, by transfecting it with human insulin cDNA under the control of the cytomegalovirus promoter. The HUH7-ins cells created were able to synthesize insulin in a similar manner to that which occurs in pancreatic b cells. They secreted insulin in a regulated manner in response to glucose, calcium and theophylline, the dose-response curve for glucose being near-physiological. Perifusion studies showed that secretion was rapid and tightly controlled. Removal of calcium resulted in loss of glucose stimulation while addition of brefeldin A resulted in a 30% diminution of effect, indicating that constitutive release of insulin occurred to a small extent. Insulin was stored in granules within the cytoplasm. When transplanted into diabetic immunoincompetent mice, the cells synthesized, processed, stored and secreted diarginyl insulin in a rapid regulated manner in response to glucose.
Introduction
Treatment of type I diabetes is by two or more injections of insulin daily. Despite this, it is often not possible to achieve perfect normalization of blood glucose levels. To obtain perfectly normal blood glucose levels attempts have been made to replace the missing b cells by transplantation of a whole pancreas, the islets from an adult pancreas, or insulin-producing fetal pancreatic cells. While transplantation of whole pancreases is of benefit in reversing diabetes in humans, with 84% 1-year graft survival, 1 its success is limited mostly to those people who have renal failure. Allografted adult human islets are capable of reversing diabetes with results improving in some 2 but not all centers. 3 Fetal pancreatic tissue is an alternative, the potential of which has not been fully realized. 4 An alternative approach to the treatment of type I diabetes is the use of liver cells that have been genetically altered to produce insulin. [5] [6] [7] [8] [9] [10] [11] [12] [13] Results of a previous study in our laboratory have shown that insertion of human insulin cDNA (pC 2 ) and the glucose transporter GLUT2 into the neoplastic human hepatoma cell line HEP G2 resulted in synthesis and storage of (pro)insulin in structures resembling the secretory granules of normal pancreatic b bcells. 6 These HEP G2ins/g cells exhibited regulated, near-physiological secretion of (pro)insulin in response to glucose. In contrast, insertion of insulin into two rat liver cell lines, FAO 7 and H4-II-E 8 , resulted in synthesis and release of insulin, but not its storage or regulated secretion.
For an insulin-producing liver cell to be of maximal benefit in vivo, it must be able to secrete a biologically active form of insulin rapidly in response to an elevated level of glucose. It is generally believed that this will require storage and processing of proinsulin to insulin in granules. Prior to this publication such granules have not been described in insulin-producing liver cells in vivo, although processing has been induced. 9, 10 Despite the absence of granules, blood glucose levels of diabetic rodents in which insulin is produced in the liver can be lowered to normal 11 or near-normal 9,10,12,13 levels. A reduction of blood glucose levels, but not to normal, can also be achieved by transplanting the rat liver cell line H4-II-E. 8 In all these rodents, even in those in which blood glucose levels were normalized, 11 secretion of insulin in response to glucose did not occur in the rapid manner seen from pancreatic b cells. In the study of Lee et al, 11 which employed a single-chain insulin analog, there was very little change in blood levels of insulin during the first hour after administration of glucose; levels began to rise after this time and peaked at 4 h. In normal rats, peak insulin levels occur 30 min after oral glucose is given.
In our current study, we describe the creation of an insulin-secreting human liver cell line by the transfection of the insulin gene into the neoplastic HUH7 cell. These new cells possess storage granules and cleave proinsulin to the bioactive diarginyl insulin. They secrete the peptide rapidly in a regulated manner in response to glucose, but there is also some constitutive release of the hormone. When transplanted into diabetic immunoincompetent mice, the cells lower glucose levels with release of insulin being partly regulated, but mostly constitutive.
Results
Gene transfer into hepatoma cells HUH7 cells were stably transfected with the pRc CMV vector carrying human insulin cDNA and 25 clones of the HUH7-ins cells were isolated for further analysis. The transfectants have remained stable for a period of greater than 6 months in continuous culture. An analysis of HUH7-ins cells showed the presence of both GLUT2 and glucokinase, a feature also of the untransfected cells. GLUT 2 mRNA and protein were shown by Northern analysis ( Figure 1a ) and Western blots (Figure 1b) , respectively, and glucokinase by RT/PCR (Figure 1c ).
Secretion of insulin
The levels of human insulin secreted daily into the culture supernatant from different clones of HUH7-ins cells differed by 1.8-fold (0.1670.0 to 0.3070.10 pmol/ 10 6 cells, n¼10). Levels of human proinsulin and its split products, but not insulin, determined by a specific radioimmunoassay (RIA) were 1071.2% of the total insulin activity measured. C-peptide levels were 0.570.1% of the total insulin activity. HUH7 cells transformed with the RcCMV vector alone did not secrete insulin.
The effect of three well-known b cell stimuli, glucose, theophylline and calcium, on the HUH7-ins cells (clone 2) was determined. A three-fold stimulation of insulin secretion over basal levels ( Figure 2a ) was detected when 20 mM glucose was applied as a stimulus to HUH7-ins cells for 1 h. As would be expected in regulated secretion, on removal of the stimulus, insulin returned to basal levels. This was confirmed by the perifusion studies (Figure 3a) . The same clone of HUH7-ins cells showed a 46-fold response to 10 mM theophylline ( Figure   2b ) and an eight-fold response to 10 mM calcium over basal levels (Figure 2c ). Insulin secretion in response to 20 mM glucose plus 10 mM theophylline resulted in a significant (Po0.01) increase in insulin secretion to 2.770.3 pmol insulin/10 6 cells, above that seen for theophylline alone (2.2 7 0.3) (Figure 2d ). Similar results to these were seen for two other clones (9 and 13).
In response to varying concentrations of glucose from 0 to 20 mM, a dose-response curve for insulin secretion was generated with clone 2 (Figure 3b ). While glucose responsiveness commenced at a slightly lower concentration than normal islets, a secretion curve approaching normal physiological conditions was generated.
To assist in confirming that secretion of insulin from the HUH7-ins cells was regulated, two extra sets of experiments involving static stimulation were performed. Firstly, calcium was removed from the basal medium before 20 mM glucose was added. This abolished the response of the cells to glucose (Figure 2e ), just as it did in MIN6 cells, which are normally glucose responsive (Ref. 14 and own results not shown). Secondly, BFA, an agent that blocks movement of proteins in the Golgi apparatus, 15 and therefore constitutive release of insulin, was added at the same time as 20 mM glucose. 
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Secretion of insulin from the HUH7-ins cells was inhibited 30% by BFA (Figure 2e ), whereas it completely eliminated secretion of proinsulin from MRC5-VI cells (human lung fibroblasts) transfected with the insulin gene that release insulin constitutively (results not shown). BFA had no effect on glucose-induced insulin secretion from MIN6 cells, secretion being enhanced by 20 mM glucose six-fold in the presence or absence of BFA. These data indicate that there is a small amount of constitutive release of insulin from HUH7-ins cells in vitro.
Insulin degradation
We examined whether the HUH7 liver cell line has the ability, like primary hepatocytes, 16 to degrade insulin. HUH7 cells cultured in DMEM medium containing 10% FCS metabolized 0.1870.04 pmol insulin/10 6 cells in 1 h and 0.6170.09 and 1.0970.03 pmol insulin/10 6 cells in 6 and 24 h, respectively (n¼6). When the HUH7 cells were maintained in Basal medium, the cells metabolized 0.1270.04 and 0.5870.05 pmol insulin/10 6 cells in 1 and 6 h, respectively (n¼6). By comparison the amount of insulin degraded by NIH 3T3 cells (negative control) was negligible. It has been known for some time that the endosomal compartment of hepatocytes contains an acidic endopeptidase or endosomal acidic insulinase, which has recently been confirmed to be cathepsin D. 17 The activity of cathepsin D is almost completely inactivated by protease inhibitors, such as pepstatin A. 17, 18 We incubated Huh7 cells over a 24-h period in DMEM medium and a 6-h period in basal medium, in the presence of pepstatin A, and confirmed that insulin degradation was negligible in the presence of the protease inhibitor.
Insulin content
The insulin content of the HUH7-ins clones, determined in acid ethanol extracts, varied by 1.6-fold from 4.270.6 to 6.970.8 pmol/10 6 cells. Proinsulin was not detectable in the cell extracts, as determined by an RIA specific for proinsulin. 6 Clones 2, 9 and 13, which were used for the acute stimulation experiments described previously, contained the largest amount of insulin, 6.970.8, 5.970.3 and 4.771.0 pmol/10 6 cells (n¼5), respectively. The percent of insulin in each cell of these three clones secreted each day was 3.6, 5.1 and 4.3, respectively. Insulin-producing liver cells BE Tuch et al
Proinsulin converting enzymes
Western blot analysis of extracts from HUH7-ins and HUH cells showed the presence of both PC1 and PC2, enzymes in b cells which cleave proinsulin (Figure 4a ). Levels of these enzymes were upregulated by transfection with the vector containing insulin cDNA, but not with an empty vector (data not shown). PC1 was detected at a molecular weight of 75 kDa in the liver cell lines, as compared to bands of size 87 and 62 kDa in MIN6 cells, which correspond to proPC1 and truncated carboxy terminal PC1, respectively. The different sizes of PC1 may be because of the variation in glycosylation related to different cell requirements for convertase processing. Two molecular weight bands of PC2 were detected in the liver cell lines, 73 and 50 kDa, as compared to 73 and 63 kDa in MIN6 cells. The former is proPC2 and the latter a cleaved version.
Histology and electron microscopy
Light microscopic analysis of the HUH7-ins cells showed the presence of insulin in the cytoplasm (Figure 5a ). Electron microscopy ( Figure 6a ) showed the appearance typical of a secretory cell, with rough endoplasmic reticulum, Golgi complex, a few large vacuoles of 0.5-4 mm diameter and secretory vesicles containing dense granules. Large vacuoles were also present in another human insulin-producing cell we have created, HEP G2ins/g cells. 6 No secretory vesicles containing granules were observed in HUH7 cells, but there were a small number of vacuoles. The secretory vesicles present in HUH7-ins cells, at 170-230 nm diameter, were smaller than the structures termed membrane sacs 300 nm in diameter, found in normal b cells. 19, 20 The dense granules in HUH7-ins cells were 85-100 nm in diameter, smaller than in a normal b cell in which mature granules are 240 nm in diameter. 19 As in normal b cells, the granules in the HUH7-ins cells were surrounded by an electronlucent area. Many granules in HUH7-ins cells had a pale area in the center of the dense granule ( Figure 6b ). In MIN6 cells processed in the same way for electron microscopy, there were both large secretory vesicles of 300 nm containing dense granules of 180 nm, and smaller vesicles with granules of the same appearance and dimensions as in the HUH7-ins cells (Figure 6c ). In both HUH7-ins and MIN6 cells, the central pale area was presumably a feature of the granule in early stage secretory vesicles. Figure 7a is an example of a secretory vesicle in an HUH7-ins cell in which the dense granule (diameter 100 nm) had a central pale area which was only 5 nm in diameter. This is presumed to be a more mature granule than those with larger central pale areas.
Immunoelectron microscopy (IEM) revealed that insulin was stored in the granules within the small secretory vesicles of HUH7-ins cells (Figures 7b and c) and in both the large and small secretory granules of MIN6 cells (not shown). These granules were surrounded by the pale, electron-lucent region of the secretory vesicle. The membrane was unstained as only uranyl acetate without lead staining was used in these preparations to avoid confusion with gold particles. Processing for IEM did not alter the dimensions of the secretory vesicles in either HUH7-ins or MIN6 cells. NIT 1 insulinoma cells previously gave similar results with this immunogold technique. 6 There was no non-specific labeling in the nucleus or elsewhere in the cell. Control HUH7 cells were negative as were HUH7-ins and MIN6 cells in the absence of the primary antibody.
(Pro)insulin synthesis
In response to varying concentrations of glucose, 0-20 mM, a dose-response curve was generated for (pro)insulin synthesis ( Figure 8 ). Half-maximal synthesis occurred at 5.4 mM glucose and the V max was 42.971.4 Â 10 3 cpm/mg DNA (n¼6), not significantly different from that for human islets. 21, 22 The ratio of (pro)insulin synthesis to total protein synthesis was 0.065 at 2.5 mM glucose, 0.196 at 10 mM glucose and 0.213 at 20 mM glucose. 
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Transplantation into diabetic SCID mice
Transplanted cells coalesced into a reddish friable mass at the site of grafting and grew rapidly, both beneath the renal capsule and subcutaneously. Subcutaneous grafts were visible 1-2 weeks after being transplanted. The blood glucose levels of all 18 diabetic mice that were transplanted became normal, 5.570.3 mM, in 5-26 days after the cells were implanted. Animals receiving cells beneath the renal capsule became normoglycemic faster than those grafted subcutaneously, median of 12 days (range 5-12) versus 18 days (range 12-26 days) ( Figure  9a ). Whether cells were injected or transplanted in a plasma clot did not alter the outcome (data not shown). Blood glucose levels continued to decline reaching subnormal levels, 1.770.2 mM, a median of 3 days (range 1-13 days) after blood glucose levels were normalized. Removal of the grafts at this time resulted in a prompt increase in the blood glucose levels to hyperglycemic values, 16.773.5 mM (Figure 9b ).
Intraperitoneal glucose tolerance test
The fasting blood glucose levels of transplanted mice, which had visible subcutaneous grafts, were lower than those of the controls, for example, in the fasting state, 2.670.4 mM versus 4.970.5 mM, Po0.001 ( Figure 10 ). Glucose levels peaked at 20 min in these grafted mice with human C-peptide detectable in the blood of these mice and rising from a fasting level of 0.1370.05 to 0.2970.08 nM (n¼4 in each group) at 20 min. Glucose levels peaked at 20-40 min in the control mice, in the blood of which human C-peptide was undetectable.
Analysis of grafts
Histological analysis of the grafts showed the presence of insulin in the cytoplasm of cells (Figure 5c ). Electron microscopic analysis showed the same features observed in the untransplanted cells, namely granules containing insulin (Figure 7d ). These granules were of size 95-143 nm, similar to those in untransplanted cells. HPLC analysis of graft extracts revealed that they contained insulin-related peptides, the main one being human carboxy extended diarginyl insulin ( Figure 11 ). There were two minor peaks detectable in the insulin RIA corresponding to split 31, 32 human proinsulin and intact human proinsulin. Only a very small peak was seen to elute at the position of mature human insulin. Western blot analysis of protein extracted showed the presence of PC1 and PC2 (Figure 4a ). PC1 and PC2 were in two forms, both as the pro-enzyme and as a cleaved product. Examination of the graft for b cell transcription factors gave the same results as that observed in the untransplanted cells, namely the presence of NeuroD, although in lower amounts, but not PDX-1 (Figure 4b ). The reduction of expression of NeuroD in grafted HUH7-ins cells also was observed in HUH-7 cells transplanted into immunoincompetent mice (data not shown).
Insulin content and secretion
The total insulin content of grafts removed from the mice was 1.570.3 pmol/100 mg, which is less than the insulin content of the pancreas of control immunoincompetent mice, 83715 pmol/mg. This suggests that regulated insulin secretion in these grafts was small, with lowering of blood glucose levels in the animals being largely the result of constitutive release of insulin. This functional difference between the cells in vitro and in vivo may be caused by the effects of transplantation, such as lower levels of oxygen, 23 which are critical for insulin secretion. When the cells in the grafts were removed from the mice and cultured in vitro, the insulin content was similar to that of untransplanted cells, 5.1-5.6 pmol/10 6 cells. The Insulin-producing liver cells BE Tuch et al amount of hormone secreted per day in vitro varied from 0.28 to 0.34 pmol/10 6 cells, that is, 5.5-6.1% of the insulin content. When cells isolated from the grafts were challenged with 20 mM glucose, insulin secretion was enhanced 1.9 to 2.6-fold, similar to that in untransplanted cells (Figure 2a ). These data indicate that the transplanted HUH7-ins cells retained their ability to secrete insulin in a regulated manner.
Discussion
We have genetically modified the neoplastic human liver cell line, HUH7, to synthesize, process, store and secrete a bioactive form of insulin in a regulated manner to the physiological stimulus glucose. These cells are not normal b cells since they also possess the capacity to release insulin in a constitutive manner. When the cells are transplanted into immunodeficient diabetic mice, blood glucose levels are lowered to normal and subsequently subnormal levels with secretion of insulin continuing to be partly regulated by glucose, but mostly constitutive. Our experience with the HUH7-ins cell line extends our results with another human liver cell line, HEP G2ins/g, which also synthesized, stored and secreted insulin in a regulated manner when exposed to glucose in tissue culture. 6 The ability of the transplanted HEP G2ins/g cells to secrete (pro)insulin in response to glucose was impaired, with the cells having no immediate effect on the blood glucose levels of the diabetic recipient mice. 24 This was different from the results we obtained with transplanted HUH7-ins cells ( Figure 10 ). Our results with the HUH7-ins cells support the conclusion of other researchers, [7] [8] [9] [10] [11] [12] [13] namely that liver cells, or at least their precursors, 9 can be genetically altered to act as b cells, and replace those which are lost in type I diabetes. What is novel about the data reported in this paper is that secretion of insulin from liver cells that possess a b cell transcription factor in vivo is regulated by glucose, albeit to a small extent. Most genetically altered liver cells that synthesize (pro)insulin do not secrete the peptide in response to glucose. [7] [8] [9] [10] 12, 13 The two exceptions are HEP G2ins/g 6 and rodents infected with an adenovirus containing the cDNA for pyruvate kinase promoter and a single-chain insulin analogue. 11 The HEP G2ins/g cells do secrete (pro)insulin rapidly in response to glucose in vitro but the cells are unstable when transplanted. 24 Secretion of the singlechain insulin analog from rats does occur when glucose is administered, but is delayed with the peak effect at 4 hours, presumably because control is at a translational level.
Rapid regulated secretion of (pro)insulin requires prior storage of this peptide in cytoplasmic granules. Such storage is a feature of HUH7-ins, HEP G2ins 5 and HEP G2ins/g cells. 6 This has been demonstrated by immunogold electron microscopy, immunohistochemistry and extraction of cell contents with acid ethanol. To the best of our knowledge, no other insulin-producing liver cell has yet been described as having this feature. In some, insulin can be observed immunohistochemically, 8, 9, 11, 13 but no supporting proof of storage has been provided. The granules in the HUH7-ins cells were up to 100 nm in size, smaller than those observed in HEP G2ins/g cells, 6 pancreatic b cell lines, 6 and primary b cells 19 but similar The number of storage granules we observed in the HUH7-ins cells was fewer than those seen in pancreatic b cells. This is consistent with there being some constitutive release of insulin as well as degradation of insulin by the liver cells. 16, 17 Neither of these features occurs in a pancreatic b cell, but insulin degradation does occur in a normal liver cell. Constitutive release is not a feature of a pancreatic b cell, but a small amount of insulin is degraded in these cells, within the secretory granules. Insulin degradation is a prominent feature of a normal liver cell. 25 What induced the formation of storage granules in the HUH7-ins cells, and for that matter, the transfected HEP G2 cells, is unknown. Such information is highly relevant in understanding how to make a substitute b cell since it is the storage of insulin in such granules that allows the b cell to secrete insulin so rapidly when needed. This feature is a hallmark of all endocrine cells. A clue to the answer lies in the analysis of the cell lines for b cell transcription factors. Both HUH7-ins cells and the parent cell line HUH7 contain NeuroD, a transcription factor essential for the formation of pancreatic b cells. 26 HEP G2ins/g cells also possess this factor (data not shown). This agent is not normally found in liver cells, being restricted to neural and pancreatic tissues. This result indicates that the human liver cell line we have used in the current study, HUH7, already had at least one feature characteristic of pancreatic b cells before it was transfected. This is not unexpected since pancreas and liver are both derived from endodermal cells, and neoplastic cells are known to regress ontogenetically when they form. 27 The absence of PDX-1, although surprising, can be explained since not all b cells need to express this transcription factor for glucose-stimulated secretion of insulin. 28 The introduction of the insulin gene under the control of the CMV promoter appears to be responsible for activating the gene(s) required for the formation of storage granules in this 'pancreatic' liver cell. The combination of these conditions is probably required for the creation of granules. These structures form neither in other cell lines transfected with the insulin gene, 7 nor in HUH7 cells in which the cDNA for insulin is introduced under the control of an inducible promoter, sheep metallothionein. 29 The plasticity of adult cells has been demonstrated on many occasions, for example, bile duct cells in the liver can be induced to form hepatocytes following bile duct ligation and treatment with chemicals such as furan or carbon tetrachloride. 30, 31 Furthermore, 34 This plasticity may play an important role in the ability of the liver to respond to abnormal mitogenic activity or to a pathological insult caused by external factors and when fully understood could possibly be harnessed in future genetic manipulation studies as a cure for disease.
The HUH7-ins cells cleaved proinsulin to diarginyl insulin, a process that requires the converting enzymes PC1 and PC2, which were present in the HUH7-ins cells. They were also present in the parent cell line, a reflection of the pancreatic nature of this human liver cell line. Liver cells do not normally possess these enzymes, but they can be induced by the introduction of the b cell transcription factor PDX-1.
9 Diarginyl insulin was capable of lowering blood glucose levels in the transplanted mice since it is equal in biological potency to insulin. 35 Secretion of insulin from the HUH7-ins cells was partially regulated, presumably being derived from the granules. This was shown in vitro in response to glucose, calcium and a stimulus of cyclic AMP, and in vivo to glucose. Secretion was tightly controlled with secretion rapidly turned on when glucose was added, and rapidly turned off when the stimulus was removed. Further support of regulated secretion was shown by the loss of glucose stimulation in the absence of calcium. In a pancreatic b cell it is the influx of extracellular calcium through voltage-activated calcium channels on the cell surface that initiates movement of insulin granules to the cell membrane and release of their contents. The step prior to opening of such channels in a b cell is depolarization of the cell membrane caused by closure of ATP-dependent potassium channels. It is possible that these channels are present in HUH7-ins cells since they are present in HEP G2ins/g cells (unpublished data). Combining all of this information leads us to hypothesize that glucose causes secretion of insulin from HUH7-ins cells by the classical pathway described in b cells. Metabolism of glucose results in an increase in the ratio of ATP:ADP, closure of the ATP-dependent potassium channels on the cell membrane, opening of the voltageactivate calcium channels, and then secretion of insulin.
Brefeldin A (BFA) is an agent that blocks passaging of proinsulin from the trans-Golgi network to granules, but has no effect on processing of proinsulin in, or secretion of insulin from the granules. 15 Addition of this agent partially blocked secretion of insulin in response to glucose, whereas it had no effect on glucose-induced insulin secretion from the pancreatic b cell line MIN6. These results imply that at least some of the insulin released, 30% (Figure 2e ), was constitutive. In vivo the situation was different. While there was some glucoseregulated secretion of insulin, most of the insulin released was constitutive. This is concluded from the low insulin content of the grafts and the occurrence of hypoglycemia in recipient mice. The glucose doseresponse curve for insulin secretion from HUH7-ins cells was near-physiological, and similar to that obtained with the HEP G2ins/g cell line. 6 Enhancement of insulin secretion commenced at 2.5 mM glucose, not quite the same as that in pancreatic b cells, 4-5 mM, 36 but much less sensitive than a pituitary cell line transfected with the insulin gene, 10 mMM. 37 It is possible that modulation of the expression of GLUT2 in the HUH7-ins cells will shift the dose-response curve to the right, to become physiological. Expression of GLUT2 in insulin-producing cell lines, for example, HEP G2ins cells, is responsible for the induction of glucose responsiveness. 6 In contrast to the dose-response curve for insulin secretion, that for insulin synthesis was exactly the same as that which occurs in pancreatic b cells. 21, 22 This implies that different metabolites of glucose are responsible for the secretion of insulin and translation of the insulin message from the nucleus. 
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In summary, we have described the creation of a primitive insulin-secreting human liver cell line, HUH7-ins. The cells possess storage granules, cleave proinsulin to diarginyl insulin, and secrete this rapidly in a regulated manner in response to glucose and other b cell stimuli. There is also constitutive release of the hormone. When transplanted into diabetic mice, the cells retain their properties of storage, processing and regulated secretion of insulin, and normalize blood glucose levels. However, constitutive release of insulin is greater than its regulated secretion, and this together with unrestricted proliferation of cells resulted in hypoglycemia. A number of changes will be required before cells of this type could potentially be used clinically. These include a decrease of sensitivity to glucose, reduction in constitutive release of insulin, removal of the oncogenic potential, introduction of a suicide gene and encapsulation of the cells to prevent their rejection. Regardless, our results offer hope that primitive liver cells can be induced to become substitute pancreatic b cells and be used as a therapy for the treatment of type I diabetes.
Materials and methods
Plasmid construction
The full-length 0.6-kb human insulin cDNA, pC 2 was cloned into the multi-cloning site of pRcCMV (cytomegalovirus promoter) (Invitrogen, San Diego, CA, USA), as previously described. 6 The pRcCMV vector expresses resistance to the eucaryocidal antibiotic neomycin/G418. HUH7 cells were transfected with 20-mg of the recombinant plasmid and vector. Transfection was accomplished by electroporation at 400 V and 500-mF in a Biorad (Biorad, Hercules, CA, USA) gene pulser at a cell concentration of 5 Â 10 6 cells/cuvette, in Dulbecco's modification of Eagles's medium (DMEM) (Trace Biosciences, Melbourne, Australia) containing no fetal calf serum (FCS). To obtain stable transfectants of HUH7 cells containing insulin cDNA, 48 h later 0.55 mg/ml of the G418 antibiotic (Gibco Laboratories, Grand Island, NY, USA) was added to the culture medium. Medium plus drugs were changed every 2-3 days. After 3-4 weeks of selection, colonies were picked and screened for production of insulin by RIA, Selected clones were expanded into mass cultures and maintained in G418-containing media throughout the course of all experiments.
Cell culture HUH7 and HUH7-ins cells were grown as monolayers in DMEM supplemented with 10% FCS (Trace Biosciences) in 5% CO 2 in air at 371C. For the latter cell line, the antibiotic G418 0.55 mg/ml was also added. MIN6 cells were grown in DMEM supplemented with 15% FCS. NIH3T3 cells were grown in DMEM with 10% FCS. MRC5-VI cells transfected with the insulin gene were grown in DMEM, supplemented with 10% FCS and 1 mg/ml G418. 38 
Extraction of peptides
Insulin was extracted from liver cells with 0.18 N HCl in 70% ethanol for 18 h at 41C. For measurement of insulin content, samples were diluted before being placed in the RIA. For high-performance liquid chromatographic analysis (HPLC), the ethanol was evaporated, the samples lyophylized and then reconstituted in 50 ml of 0.1% trifluoroacetic acid/0.1% bovine serum albumin (BSA).
Insulin secretion
This was carried out in two ways: (a) static stimulation and (b) perifusion.
Static stimulation
39
: Before stimulation, tissue culture plates were thoroughly washed with basal medium (Phosphte-buffered saline (PBS) containing 1 mM CaCl 2 and supplemented with 20 mM HEPES and 2 mg/ml BSA, 1.0 mM glucose (unless otherwise stated)) to remove culture medium and FCS. Monolayers were incubated in the basal medium at pH 7.4 for two consecutive periods of 1 h to stabilize the basal secretion of insulin. Monolayers were then exposed to stimuli for 1 h. Glucose, 1.25-20 mM, and theophylline 10 mM (Sigma, St Louis, MI, USA) were dissolved in basal medium. When BFA (Sigma) was added, it was present at 10 mg/ml (35 mM) and was diluted from a 10 mg/ml (35 mM) stock made up in absolute ethanol and stored at À201C. Calcium (10 mM) was dissolved in basal medium without phosphate. Three controls were used -basal medium alone, basal medium without phosphate and basal medium with ethanol. The static stimulation performed in the absence of calcium had 0.15 mM EGTA in the basal medium to chelate calcium from the cell.
Perifusion: Cells were grown on cytodex 3 beads and cultured in spinner flasks in normal culture medium for 4 days. 6 Beads with cells (approximately 10 8 ) attached were transferred to a column, connected to a peristaltic pump and fraction collector, and basal medium was pumped through the system for 40 min. This was followed by a 30 min stimulus with glucose and a further 30 min basal period. Samples were collected every 2 min and assayed for insulin.
Insulin degradation
Huh7 and NIH3T3 cells (negative control) were seeded at 10 6 cells/well in DMEM, 10% FCS and incubated overnight. The medium was then replaced with DMEM or basal medium supplemented with 0.6 pmol/ml insulin and the cells were incubated for 1, 6 or 24 h (cells in basal medium for 1 and 6 h only). Prior to collection, the culture supernatant was acidified to pH 4.0 with acetic acid for 5 min. The pH of the collected supernatants was neutralized with NaOH before the samples were placed in the RIA. Insulin degradation was also measured in Huh7 cells following 24 h incubation with pepstatin A (Sigma) (0.1-5 mg/ml) 17 in DMEM medium and a 6 h incubation in basal medium.
Insulin synthesis
After trypsinization, 10 6 HUH7-ins cells were incubated at 371C (5% CO 2 /95% O 2 ) in vials containing 2 ml KrebsRinger bicarbonate buffer supplemented with 10 mM HEPES, 2 mg/ml BSA (KRB/BSA), 50 mCi/ml L-[4, H] leucine and 2.5-20 mM glucose. After 2 h, the cells were washed with KRB-BSA containing 0.05% nonradioactive leucine and disrupted by sonication in 200 ml distilled water. The amount of labeled insulin was determined by an immunoprecipitation technique as previously described. 40 Insulin-producing liver cells BE Tuch et al
RNA preparation and Northern (RNA) blot
Total cellular RNA was isolated by the guanine thiocyanate method. 41 Northern blot analysis was carried out as previously described. 6 Blots were hybridized with 32 Plabeled human GLUT 2.
Analysis of gene expression by RT/PCR
RNA (1 mg) was reverse transcribed using Moloney murine leukemia virus reverse transcriptase and random hexaneucleotide primers 42 (Perkin/Elmer, Norwalk, IN, USA). The PCR reaction was performed using a cDNA amount representing 100 ng total RNA and 1 unit of Amplitaq polymerase (Perkin/Elmer) in a reaction mix containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 0.01% (w/v) gelatin, 250 mM dNTP's and 20 pmol of each primer. The PCR was performed in a Corbett Thermal Sequencer: following an initial denaturation step of 2 min at 941C, a 35 cycle program consisting of 941C for 45 s, 611C for 1 min and 721C for 45 sec was performed. This was followed by a final cycle at 721C for 5 min, prior to cooling to 41C. Following PCR, a 10 ml aliquot was subjected to 12% polyacrylamide gel electrophoresis, prior to ethidium bromide staining and photography. The gene specific human glucokinase (gift from M. Permutt, St Louis, Missouri, USA) forward PCR primer was 5 0 CTACTTGGAACAAATCGCCC, and the reverse PCR primer was 3 0 CCTCCTCCTGGACTTCTTCC (primers synthesized by Gibco Laboratories). This primer pair generated a 155 bp PCR product from bp 244-379 of the published human glucokinase sequence. 43 Several negative control reactions were included in each experiment. Some of the negative controls contained water instead of cDNA, and other control reaction mixtures were prepared without the addition of RNA. All necessary precautions against contamination of PCRs were rigorously observed.
Source of mice
Male, inbred SCID mice were obtained from the Walter and Eliza Hall Institute of Medical Research in Melbourne, Victoria, Australia. They were housed in sterilized polycarbonate cages covered with autoclavable filter tops, six to a cage, and had unlimited access to sterilized tap water and gamma-irradiated mouse food. The temperature of the room in which they were housed was 171-241C and the relative humidity 53-76%.
Induction of diabetes
Diabetes was induced in the mice by injection of multilow-dose streptozotocin 75 mg/kg/day for five consecutive days. 44 This technique was used in preference to a single dose of streptozotocin because of lower morbidity. Blood glucose levels were measured on 5 ml blood obtained from a tail vein with the blood being placed on glucose reagent strips (Bayer Diagnostic, Mulgrave, Victoria, Australia) and the blood glucose level read in a glucometer (Bayer Diagnostics). The blood glucose levels of the 18 mice transplanted were 21.471.2 mM.
Transplantation of HUH7-ins cells
HUH7-ins cells were trypsinized from culture flasks, their concentration determined with a hemocytometer, and aliquots of 1 Â 10 7 cells were transplanted into the mice either by direct injection or in a plasma clot.
For the direct injection, the HUH7-ins cells were initially aspirated into polyethylene tubing (internal diameter 0.48 mm; external diameter 0.96 mm) attached to a 23-gauge needle placed on a Hamilton syringe. The end of the tubing was then inserted either beneath the left renal capsule of the mice 45 or into the subcutaneous tissues above the right scapula before the plunger of the syringe was rotated to allow injection of the cells into the mice. Six mice were transplanted in this way, three beneath the renal capsule and three subcutaneously. In a further five diabetic mice the cells were injected subcutaneously using a 1 ml syringe attached to a 23-gauge needle without the polyethylene tubing.
A further seven mice were subsequently transplanted with cells placed in a plasma clot, 46 five having grafts placed beneath the renal capsule and two subcutaneously.
Blood glucose levels and weight of the mice were monitored every 1-3 days. Insulin was not administered to the mice at any time, as is sometimes done to reduce mortality and morbidity. Grafts were removed from the mice when the blood glucose levels became low. Blood glucose levels of the mice were monitored thereafter, an increase expected if the graft had been responsible for reversal of the diabetes.
Intraperitoneal glucose tolerance test
An intraperitoneal glucose tolerance test was performed in mice transplanted with HUH7-ins cells, both before and after blood glucose levels became normal. This was carried out on mice fasted overnight. A total of 8.3 mmol/ g body weight of a 1.67 M glucose solution was injected intraperitoneally, blood glucose levels measured at 0, 10, 20, 40, 60, 90 and 120 min thereafter, 47 and human Cpeptide levels at 0 and 20 min.
RIA
Levels of human proinsulin (hPI) were measured by an RIA specific for this peptide and its split products as described previously. 6, 48 Iodinated hPI was prepared by the chloramine-T method. Specificity was established by showing o0.05% cross-reactivity with insulin. The insulin RIA was carried out using guinea pig insulin antibody (Wellcome, England) and 125 I-labeled insulin prepared by the chloramine-T method (gift from Dr Paul Williams, University of Sydney). Cross-reactivity with hPI was 73%. Human insulin standards were used to assay the product from HUH7-ins cells and rat insulin standards for MIN6 cells.
A commercial RIA (Eurodiagnostica, Malmö , Sweden) was used to measure levels of human C-peptide. The antibody used in the assay does not detect human insulin but there is 41% cross reactivity with human proinsulin.
Membrane preparation, gel electrophoresis and Western blotting
Cell membranes were prepared from HEP G2, HUH7, HUH7-ins and MIN6 cells by suspending cells in ice-cold buffer (20 mM K 2 HPO 4 , 1 mM EDTA and 110 mM KCl) containing protease inhibitors, and sonicating cells on ice. Supernatants were prepared by centrifugation at 16 000 g in a refrigerated microfuge and the protein concentration determined by the method of Bradford. 49 A total of 5 mg of protein was suspended in an equal 
Immunohistochemical analysis
HUH7 and HUH7-ins cells were collected after trypsinization, or from transplanted mice, and fixed in 10% formalin at 41C for 2 h. They were then washed in PBS and loaded onto slides coated with poly-L-lysine (Sigma). The endogenous peroxidase was inactivated by treatment of cells with 3% hydrogen peroxide. Prior to antibody labeling, 10% goat serum was applied to the samples to prevent non-specific antibody labeling. The cells were incubated with the primary antibody (guinea pig polyclonal insulin antibody (1:1000)) overnight at 41C. After washing in PBS the cells were allowed to react with the secondary antibody (guinea pig, anti-rabbit immunoglobulin (1:500)) for 30 min at room temperature. This was followed by sequential labeling with biotinylated anti-rabbit immunoglobulin and streptavidin-peroxidase conjugate. Coloration was produced with substrate solution containing hydrogen peroxidase and 3-amino-9-ethylcarbazole (red) or diamino-benzidine (brown). For the negative control, primary antibody was omitted by replacing the antibody with PBS. Pig pancreas was immunohistochemically stained to serve as the positive control. After immunostaining the nuclei were counterstained with Mayer's hematoxylin (Sigma). All immunoglobulins and AEC substrate were purchased from Dako (Santa Barbara, CA, USA).
Electron microscopy
After trypsinization, single cell suspensions were allowed to settle between changes of solutions as follows: control HUH7 cells and HUH7-ins cells were fixed for 2 h at room temperature in 3% glutaraldehyde and 1.5% formalin with 30 mM betaine in 0.17 cacodylate buffer, pH 7.4, osmolarity 1200 mOsM, followed by 1.5% osmium tetroxide in 1 M cacodylate buffer at room temperature for 30 minutes. Subsequent processing was as detailed by Swan.
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Engrafted cells: 1 mm 3 fragments of grafts from the transplanted mice were fixed in 2% glutaraldehyde and 1% paraformaldehyde for 1 h at 41C in 0.1 M cacodylate buffer at pH 7.4, followed by 1% osmium tetroxide for 1 h at 41C. A block stain was carried out in aqueous 2% uranyl acetate at room temperature for 1 h. Tissue was dehydrated in solutions of graded alcohol and embedded in Durcupan (Fluka, Switzerland). Ultra-thin sections (80 nm) were cut on a Reichert Ultracut-S and counterstained with Reynold's lead citrate and examined at 80 kV on a JEOL 100C electron microscope. Granule size was measured directly from the image.
For immunoelectronmicroscopy, a post-embedding immunogold procedure was used to localize intracellular insulin. Single cell suspensions of control HUH7, HUH7-ins and MIN6 cells (mouse pancreatic b cell line, used as a positive control) were fixed for 2 h at room temperature in 4% formalin in 0.1 M phosphate buffer containing 40 mM betaine, pH 7.4. Cells were allowed to settle between washes of PBS, 0.9% sodium chloride, ethanol series to 70% followed by embedding in freshly made LR White. Cells were centrifuged gently at 0.2 rcf for 10 min. in a MiniSpin Plus Eppendorf centrifuge for the last embedding step only. Hardening was at 481C for 48 h. Sections were cut using a MT-1 microtome and labeling procedures were carried out immediately after sectioning as described by Saccomano et al, 51 with particular details as follows: non-specific binding was blocked using 1% BSA and 1% glycine in PBS at room temperature for 2 h. A goat anti-mouse IgG (EMGMHL 10) 10 nm gold probe 1:50 (BBInternational, Australian Laboratory Services Pty Ltd, Sydney, Australia) incubated for 2 h at room temperature was directed against a monoclonal mouse anti-human insulin (1:70) primary antibody (BioGenex, San Ramon, CA, USA) incubated overnight at 41C. Primary antibody was replaced by PBS to assess the level of non-specific binding of the gold probe. Sections were stained with 1.5% aqueous uranyl acetate alone for 9 min before observing at 80 kV in a JEOL 100C electron microscope. Lead citrate staining was not performed, to avoid confusion between possible lead precipitates and gold particles.
Reverse phase high-performance liquid chromatography (RP-HPLC) for separation of insulinrelated peptides
The HPLC system consisted of a 1050 Hewlett-Packard pump with a Merck (Darmstadt, Germany) LiChrospher 100 RP-18 (5 mm) 250 Â 4 mm column with a guard cartridge. Cell extract samples (100 ml each) were loaded on the HPLC column and eluted at a rate of 1 ml/min with the following two buffer system: Buffer A: 3.4 ml concentrated H 3 PO 4 , 14 g NaClO 4 , 2.2 g heptanesulfonic acid monohydrate sodium salt brought to pH 3; Buffer B: 90% acetonitrile in H 2 O. Solution B was held at 38% for 30 min for insulin elution and then linearly increased to 42% over 65 min for elution of proinsulin-related peptides; for column wash solution B was then increased to 60% over 10 min, held at 60% for 5 min and then linearly decreased over 10 min to 38%. Absorption at 217 nm was monitored with a spectrophotometric detector (Jasco, Tokyo, Japan). Fractions of 1 ml were collected in tubes containing 0.1 ml 0.5 M boric acid, 0.1% BSA. For determination of insulin and its related peptides, the samples were dried in a Speed-Vac apparatus and reconstituted for radioimmunoanalysis in 0.5 ml PBS/ 0.1% BSA. Human insulin was determined by standard RIA as described. 52 Elution positions of human insulin, diarginyl insulin, split 31,32 proinsulin, split 65,66 proinsulin and intact proinsulin were determined with 
Statistical analysis
Data were analyzed with the computer statistical package NCSS. 53 Statistical significance of differences between groups was tested by Student's paired t-test or, if there were more than two groups, by one-way analysis of variance after log transformation of the data. Where the P-value for the latter test was o0.05, the differences between individual groups were evaluated with Duncan's multiple range test.
